OurCrowd (Investment in Syque Medical) LP — Form D
OurCrowd (Investment in Syque Medical) LP of JERUSALEM, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2015-12-01. The offering totals $2.2M, of which $2.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2015-12-01
- Form: D
- Accession: 0001465818-15-000040
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.1
- Total offering: $2.2M
- Amount sold: $2.0M
- Remaining: $200K
- Minimum investment: $10K
- Investors: 98
- Date of first sale: 2015-06-19
- Security types: equity, fund interests
- Revenue range: Not Applicable
- SEC file number: 021-252125
Issuer
- Name: OurCrowd (Investment in Syque Medical) LP
- CIK: 0001658178
- Entity type: Limited Partnership
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2015
- Address: 28 DERECH HEBRON, JERUSALEM, L3, 9108001
- Phone: 972-2-636-9300
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jonathan Medved | Director | Jerusalem, L3 |
| Jonathan Medved | Executive Officer | Jerusalem, L3 |
| Robert Citron | Executive Officer | Jerusalem, L3 |
| Jay Kalish | Executive Officer | Jerusalem, L3 |
| Steven Blumgart | Director | Jerusalem, L3 |
| Steven Blumgart | Executive Officer | Jerusalem, L3 |
Other filings by this issuer (1)
More